-transparent.png){kind=logo}
A Case of Pancreatic Neuroendocrine Tumor G3 Which Responded Remarkably to Chemotherapy. 2022
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan.
Pancreatic neuroendocrine carcinoma (NEC) as classified in the World Health Organization (WHO) 2010 was reclassified in the WHO 2017 as either neuroendocrine tumor (NET) G3 or NEC. An accurate diagnosis based on the WHO 2017 classification is important in order treating this disease appropriately. We report a case diagnosed as NET G3 that responded remarkably well to treatment with streptozocin. The patient would likely not have received the streptozocin treatment if she had been diagnosed with NEC. The WHO 2017 classification is reasonable for the treatment of advanced pancreatic neuroendocrine neoplasms.
Related Publications
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
March 1987,
Japanese journal of clinical oncology,
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
November 2000,
Gan to kagaku ryoho. Cancer & chemotherapy,
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
December 2015,
Clinical journal of gastroenterology,
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
November 1998,
Gan to kagaku ryoho. Cancer & chemotherapy,
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
May 2019,
Annals of surgical oncology,
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
September 1990,
Gan no rinsho. Japan journal of cancer clinics,
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
March 2015,
Frontiers of medicine,
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
March 1984,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
January 2017,
Case reports in oncology,
Satoru Nebuya, and
Shinji Oe, and
Yoshikazu Harada, and
Yusuke Takeuchi, and
Akitoshi Yoneda, and
Yudai Koya, and
Koichiro Miyagawa, and
Yuichi Honma, and
Michihiko Shibata, and
Masaru Harada
March 2017,
Pancreas,
